PurposeSpindle cell and sclerosing rhabdomyosarcoma (sRMS/scRMS) are rare variants accounting for 5%–10% of all RMS cases. This study aimed to evaluate the feasibility of using drug sensitivity assay to guide real time treatment decisions in children with sRMS/scRMS.MethodsWe retrospectively analyzed 14 consecutive patients diagnosed with sRMS/scRMS between January 2020 and December 2024. All pat…
